Relative DA1-Dopamine-Receptor Agonist and α-Adrenoceptor Antagonist Activity of Fenoldopam in the Anesthetized Dog
| Autor: | Jai D. Kohli, Leon I. Goldberg, Dana Glock |
|---|---|
| Rok vydání: | 1988 |
| Předmět: |
Agonist
medicine.medical_specialty Pentobarbital Fenoldopam medicine.drug_class Vasodilator Agents Blood Pressure Dopamine agonist Receptors Dopamine Renal Circulation chemistry.chemical_compound Dogs Internal medicine medicine Animals Phenylephrine Adrenergic alpha-Antagonists Pharmacology SCH-23390 business.industry Antagonist Benzazepines Endocrinology chemistry Vascular Resistance medicine.symptom Cardiology and Cardiovascular Medicine business Vasoconstriction medicine.drug |
| Zdroj: | Journal of Cardiovascular Pharmacology. 11:123-126 |
| ISSN: | 0160-2446 |
| DOI: | 10.1097/00005344-198801000-00018 |
| Popis: | Relative DA1-dopamine-receptor agonist and alpha-adrenoceptor antagonist activities of fenoldopam were determined in pentobarbital anesthetized dogs. The renal vasodilating effect of intravenous infusions of fenoldopam was used as an index of its DA1-agonist activity. Inhibition by fenoldopam of femoral vasoconstriction produced by intraarterial administration of phenylephrine (a relatively selective alpha 1 agonist) and UK 14,304 ( a relatively selective alpha 2 agonist) was used to determine its alpha-adrenoceptor antagonist activity. Intravenous infusions of 0.1 and 0.2 microgram/kg/min of fenoldopam caused dose-related reductions in renal vascular resistance and mean arterial pressure. Higher rates of infusions of fenoldopam (2 and 5 micrograms/kg/min) were given after pretreatment with 50 micrograms/kg/min SCH 23390 (a DA1-selective antagonist) to attenuate DA1-mediated hemodynamic effects. After SCH 23390, the infusion of 5 micrograms/kg/min of fenoldopam produced approximately the same hypotensive and renal vasodilating actions as the 0.2 microgram/kg/min infusion without SCH 23390. Alpha-adrenoceptor blocking activity was not observed with the 0.1, 0.2, and 2 micrograms/kg/min infusions of fenoldopam. The 5 micrograms/kg/min infusion, however, produced 14 and 25% inhibition of the vasoconstrictor effects of phenylephrine and UK 14,304, respectively. These data indicate that fenoldopam decreases renal vascular resistance in doses which are 25 to 50 times less than the dose needed to antagonize alpha adrenoceptors. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|